Micotherapy U-CARE
Micotherapy U-CARE
Powerful immune modulator with exclusive AVD proprietary formula
From organic cultivation (IT BIO 006) – Made in Europe
Properties
Micotherapy U-CARE is a proprietary blend of A.V.D. REFORM based on concentrated hydroalcoholic extracts of 5 mushrooms traditionally considered “medicinal” and selected among those with greater efficacy in immune support action: Reishi (Ganoderma lucidum), Maitake (Grifola frondosa), Agaricus blazei, Cordyceps sinensis, Shiitake (Lentinula edodes). This specially designed formula contains polysaccharides (1.3 – 1.6 Betaglucans) with high immunomodulatory activity, triterpenes, ergothioneine, ergosterols and numerous other biologically active compounds to support the health of the body.
The extracts contained in Micotherapy U-CARE have been shown to have immunomodulatory activity, but also to enhance the microbiota, reduce inflammation, improve antioxidant protection, factors that translate into an improvement in the quality of life.
The synergy of beta-glucans obtained from different species of mushrooms allows for a more complete action on the immune system. The product enhances, through the microbiota, the first line of immune defense, the non-specific one, and indirectly helps to correctly modulate the specific one, making it also suitable for individuals with immune deregulation. .
Physiological effects
It modulates the immune defenses and protects the body at 360 degrees.
Ingredients
Mixture of Beta-glucans extracted from the following organic mushrooms:
- Agaricus blazei
- Cordyceps sinensis
- Ganoderma lucidum
- Grifola frondosa
- Lentinula edodes
| AVERAGE CONTENT OF CHARACTERIZING INGREDIENTS | PER DAILY DOSES (2 CPS) |
| Betaglucans extracted from: | |
| Ganoderma lucidum | 300 mg |
| Grifola frondosa | 300 mg |
| Agaricus blazei | 300 mg |
| Cordyceps sinensis | 300 mg |
| Lentinula edodes | 300 mg |
Instructions for use
2 capsules per day, preferably away from meals.
It is recommended to take vitamin C at the same time
Format
Pack of 70 capsules
Notes
NO OGM
listed in the supplement register: code 627
EAN code: 8059173430833
Paraf. code: 979605007
Bibliography
- Anticancer and anti-inammatory properties of Ganoderma lucidum extract effects on melanoma and Triple-Negative Breast Cancer treatment. Barbieri A, Quagliariello V, Del Vecchio V, Falco M, Luciano A, Amruthraj NJ, Nasti G, Ottaiano A, Berretta M, Iaffaioli RV, Arra C. Nutrients. 2017 Mar; 9(3): 210
- B-glucans from Grifola frondosa and Ganoderma lucidum breast cancer: an example of complementary and integrative medicine. Rossi P, Difrancia R, Quagliariello V, Savino E, Tralongo P, Randazzo CL, Berretta M. Oncotarget. 2018 May 15;9(37):24837-24856
- Immunomodulatory and Antitumoral Properties of Ganoderma lucidum and Agaricus brasiliensis (Agaricomycetes) Medicinal Mushrooms. Rubel R, Santa HSD, Dos Santos LF, Fernandes LC, Figueiredo BC, Soccol CR. Int J Med Mushrooms. 2018;20(4):393-403
- The Potential Role of Medicinal Mushrooms in the Prevention and Treatment of Gynecological Cancers: A Review. Venturella G, Saporita P, Gargano ML. Int J Med Mushrooms. 2019;21(3):225-235
- The effects of beta-glucan on human immune and cancer cells. Chan GC, Chan WK, Sze DM. J Hematol Oncol. 2009 Jun 10;2:25
- Optimizing Tumor Microenvironment for Cancer Immunotherapy: β-Glucan-Based Nanoparticles. Mei Zhang, Julian A. Kim, and Alex Yee-Chen Huang. Front Immunol. 2018; 9: 341
- Glucans as New Anticancer Agents. Sima P, Richter J, Vetvicka V. Anticancer Res. 2019 Jul; 39(7):3373-3378
- Consumption of β-glucans to spice up T cell treatment of tumors: a review. de Graaff P, Govers C, Wichers HJ, Debets R. Expert Opin Biol Ther. 2018 Oct;18(10):1023-1040
- Cytotoxic lanostane-type triterpenoids from the fruiting bodies of Ganoderma lucidum and their structure-activity relationships. Chen S, Li X, Yong T, Wang Z, Su J, Jiao C, Xie Y, Yang BB. Oncotarget. 2017 Feb 7;8(6):10071-10084
- Biological activities of triterpenes isolated from the medicinal mushroom Ganoderma lucidum. Dudek MK, Loganathan J, Silva D, Glensk M. Planta Medica 2015; 81(11)
- Anti-oxidative Amino Acid L-ergothioneine Modulates the Tumor Microenvironment to Facilitate Adjuvant Vaccine Immunotherapy. Yoshida S, Shime H, Matsumoto M, Kasahara M, Seya T. Front Immunol. 2019 Apr 4;10:671
- Yeast-Derived β-Glucan in Cancer: Novel Uses of a Traditional Therapeutic. Geller A, Rejeena S, and Yan J. Int J Mol Sci. 2019 Aug; 20(15): 3618
- Imprime PGG, a yeast β-glucan PAMP elicits a coordinated immune response in combination with anti-PD1 antibody. Xiaohong Q, Chan ASH, Adria Bykowski J, Kangas T, Nadine R., Jeremy R. Graff and Bose N. J Immunol May 1, 2016, 196 (1 Supplement) 214.16
- Tumor Microenvironment as a New Target for Tumor Immunotherapy of Polysaccharides. Liu L, Nie S, Xie M. Crit Rev Food Sci Nutr. 2016 Jul 29;56 Suppl 1:S85-94
- Can maitake MD-fraction aid cancer patients? Kodama N, Komuta K, Nanba H. Altern Med Rev. 2002;7:236–239
- Anti-tumor monoclonal antibodies in conjunction with β-glucans: a novel anti-cancer immunotherapy Xiang D, Sharma VR, Freter CE, Yan J. Curr Med Chem. 2012;19(25):4298-305
- Ganoderma lucidum (Reishi) suppresses proliferation and migration of breast cancer cells via inhibiting Wnt/β-catenin signaling. Zhang Y. Biochem Biophys Res Commun. 2017 Jul 8;488(4):679-684
Benefits
It modulates the immune defenses and protects the body at 360 degrees.
In-house production cycle
We produce our supplements in our in-house laboratories to ensure performance and safety.
Useful product codes
- listed in the supplement register: code 627
- Paraf. Code: 979605007
Reviews